Long-Term Liabilities: The sum of all non-current liabilities.
Athira Pharma, Inc. (ATHA) had Long-Term Liabilities of $0.46M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-6.61M |
|
-- |
|
-- |
|
$6.87M |
|
$-6.87M |
|
$0.26M |
|
$-6.61M |
|
$-6.61M |
|
$-6.61M |
|
$-6.61M |
|
$-6.61M |
|
$-6.61M |
|
$-6.87M |
|
$-6.70M |
|
3.94M |
|
3.94M |
|
$-1.68 |
|
$-1.68 |
|
| Balance Sheet Financials | |
$27.02M |
|
$1.72M |
|
$3.01M |
|
$30.03M |
|
$2.79M |
|
-- |
|
|
Long-Term Liabilities |
$0.46M |
$3.25M |
|
$26.79M |
|
$26.79M |
|
$26.79M |
|
3.94M |
|
| Cash Flow Statement Financials | |
$-26.33M |
|
$-1.26M |
|
$0.02M |
|
$49.07M |
|
$21.50M |
|
$-27.56M |
|
$4.64M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.70 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-26.33M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-24.68% |
|
-24.68% |
|
-22.01% |
|
-24.68% |
|
$6.79 |
|
$-6.68 |
|
$-6.68 |
|